VA
SRCL

Vident Advisory’s Stericycle Inc SRCL Stock Holding History

Vident Advisory’s Portfolio SRCL Stock Details SRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,958
Closed -$230K – 1588
2024
Q2 		$230K Buy
+3,958
New +$203K 0.01% 1227

Other funds holding SRCL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vident Advisory's SRCL Position: Q3 2024 in Review

Vident Advisory sold out of Stericycle Inc (SRCL) in Q3 2024, closing a stake of 3,958 shares — an estimated $230K sold.

Vident Advisory first reported a position in SRCL in Q2 2024 and held it in 1 quarter. The position peaked at $230K in Q2 2024. 342 funds tracked by Wall St. Rank hold SRCL as of Q3 2024.

  • Vident Advisory reported no remaining Stericycle Inc position as of Q3 2024 after selling out during the quarter.
  • Vident Advisory sold 3,958 Stericycle Inc shares in Q3 2024, an estimated $230K.
  • Vident Advisory first reported a position in Stericycle Inc in Q2 2024 and held it in 1 quarter.
  • Vident Advisory's Stericycle Inc position peaked at $230K in Q2 2024.
  • 342 funds tracked by Wall St. Rank held Stericycle Inc as of Q3 2024.

Based on Vident Advisory's 13F filing for Q3 2024, filed 14 Nov 2024.